Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bilal Unal

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biomarker Research|December 10, 2025
Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppressionBilal Unal, Fahri Saatcioglu
Cellular and Molecular Life Sciences : CMLS|February 6, 2016
Reactivation of telomerase in cancerSemih Can Akincilar, Bilal Unal, Vinay Tergaonkar
Trends in Molecular Medicine|December 17, 2017
Noncoding RNAs: Master Regulators of Inflammatory SignalingChen Li Chew, Stephanie Ana Conos, Bilal Unal, et al.
Theranostics|December 4, 2024
Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease managementStian Bakke Hansen, Bilal Unal, Omer Faruk Kuzu, et al.
The British Journal of Occupational Therapy|May 27, 2025
Validity and reliability of the Turkish version of "The Occupational Circumstances Assessment Interview and Rating Scale" in rheumatic diseasesGokcen Akyurek, Gonca Bumin, Gozde Onal, et al.
Cancer Discovery|September 22, 2016
Long-Range Chromatin Interactions Drive Mutant TERT Promoter ActivationSemih Can Akıncılar, Ekta Khattar, Priscilla Li Shan Boon, et al.
American Journal of Cancer Research|February 10, 2022
STAMP2 suppresses autophagy in prostate cancer cells by modulating the integrated stress response pathwayJørgen Sikkeland, Matthew Yoke Wui Ng, Hatice Zeynep Nenseth, et al.
Gut|November 26, 2020
<i>NAIL</i>: an evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitisSemih Can Akıncılar, Lele Wu, Qin Feng Ng, et al.
Nature Communications|October 15, 2024
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancerBilal Unal, Omer Faruk Kuzu, Yang Jin, et al.
Nature Cell Biology|January 17, 2025
Retraction Note: Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastomaLele Wu, Zheng Zhao, Yong Jae Shin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biomarker Research|December 10, 2025
Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppressionBilal Unal, Fahri Saatcioglu
Cellular and Molecular Life Sciences : CMLS|February 6, 2016
Reactivation of telomerase in cancerSemih Can Akincilar, Bilal Unal, Vinay Tergaonkar
Trends in Molecular Medicine|December 17, 2017
Noncoding RNAs: Master Regulators of Inflammatory SignalingChen Li Chew, Stephanie Ana Conos, Bilal Unal, et al.
Theranostics|December 4, 2024
Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease managementStian Bakke Hansen, Bilal Unal, Omer Faruk Kuzu, et al.
The British Journal of Occupational Therapy|May 27, 2025
Validity and reliability of the Turkish version of "The Occupational Circumstances Assessment Interview and Rating Scale" in rheumatic diseasesGokcen Akyurek, Gonca Bumin, Gozde Onal, et al.
Cancer Discovery|September 22, 2016
Long-Range Chromatin Interactions Drive Mutant TERT Promoter ActivationSemih Can Akıncılar, Ekta Khattar, Priscilla Li Shan Boon, et al.
American Journal of Cancer Research|February 10, 2022
STAMP2 suppresses autophagy in prostate cancer cells by modulating the integrated stress response pathwayJørgen Sikkeland, Matthew Yoke Wui Ng, Hatice Zeynep Nenseth, et al.
Gut|November 26, 2020
<i>NAIL</i>: an evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitisSemih Can Akıncılar, Lele Wu, Qin Feng Ng, et al.
Nature Communications|October 15, 2024
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancerBilal Unal, Omer Faruk Kuzu, Yang Jin, et al.
Nature Cell Biology|January 17, 2025
Retraction Note: Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastomaLele Wu, Zheng Zhao, Yong Jae Shin, et al.
Pageof 2